Marketplace Donate Now Become a Member

Cart (0)

Already a DIA Member? Sign in. Not a member? Join.

Not a Member?

Renaissance Washington DC Downtown Hotel

Jan 26, 2015 8:30 AM - Jan 28, 2015 4:00 PM

999 Ninth Street NW, Washington, DC 20001

Pharmacovigilance and Risk Management Strategies 2015

Featured

Want to learn more about Pharmacovigilance and Risk Management Strategies 2015? You've come to the right site!

To keep you at the forefront.

Introduction to Pharmacoepidemiology and Applications in Premarketing and Postmarketing Surveillance, Risk Management and Value Demonstration:

PBRERs:

Pharmacovigilance and Risk Management Planning:

Pharmacovigilance System Master File:

Introduction to Pharmacoepidemiology and Applications in Premarketing and Postmarketing Surveillance, Risk Management and Value Demonstration:

PBRERs:

Pharmacovigilance and Risk Management Planning:

Pharmacovigilance System Master File:

William Gregory, PHD Senior Director, Safety and Risk Management
Pfizer Inc, United States
Stella Blackburn, MD, MA, MSC, FFPM, FISPE, FRCP Strategy
Consultant, United Kingdom
Mariette Boerstoel-Streefland, MD, MBA, MS Senior Vice President, Patient Safety Officer
Bristol Myers Squibb, United States
JP Clement, MD Founder and Principal
JPCC Associates, United States
Stephen Knowles, MD, MRCP Chief Medical Officer
Halozyme Therapeutics, United States
Michael Richardson, MD, FFPM, FRCP Senior Vice President, WorldWide Patient Safety
Bristol-Myers Squibb, United Kingdom
Tracy Salaam, PHARMD Regulatory Policy Analyst
FDA, United States
E. Stewart Geary, MD MD, Global Safety Officer
Eisai Co., Ltd., Japan